1983
DOI: 10.1007/bf01254922
|View full text |Cite
|
Sign up to set email alerts
|

Leistungsbilanz der Inselzellen nach Pankreasgangocclusion ? ein Langzeitversuch

Abstract: The transduodenal occlusion of the pancreatic duct with Prolamin (Ethibloc) was carried out in an experiment with 38 Göttinger minipigs. Occlusion of the pancreatic duct leads to selective atrophy of the excretory pancreatic parenchyma. Up until now it has not been clear whether the endocrine functional capacity of the gland stays intact in a long-term experiment or whether the islands of Langerhans are also altered by the pancreatic duct occlusion. The following tests were carried out by us to determine the e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1989
1989
2006
2006

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Anastomotic dehiscence with consecutive peritonitis occurs in up to 20% of the cases, even in recent studies [4][5][6][7]. To protect the pancreatic anastomosis, several perioperative measures have been proposed: duct liga-tion [8,9], duct occlusion with prolamin [10] or fibrin glue [11][12][13], administration of the somatostatin analogue octreotide to inhibit production of pancreatic juice [14,15], drainage techniques such as external drainage of the jejunal loop [16,17], internal stenting of the pancreatic duct [18,19], external drainage of the pancreatic duct [20][21][22], or a variety of technical modifications of the pancreatojejunal anastomoses [23,24]. Furthermore, the choice of suture material differs from center to center, and non-absorbable, as well as absorbable sutures, or both types combined, are employed [28,29,35,36].…”
mentioning
confidence: 99%
“…Anastomotic dehiscence with consecutive peritonitis occurs in up to 20% of the cases, even in recent studies [4][5][6][7]. To protect the pancreatic anastomosis, several perioperative measures have been proposed: duct liga-tion [8,9], duct occlusion with prolamin [10] or fibrin glue [11][12][13], administration of the somatostatin analogue octreotide to inhibit production of pancreatic juice [14,15], drainage techniques such as external drainage of the jejunal loop [16,17], internal stenting of the pancreatic duct [18,19], external drainage of the pancreatic duct [20][21][22], or a variety of technical modifications of the pancreatojejunal anastomoses [23,24]. Furthermore, the choice of suture material differs from center to center, and non-absorbable, as well as absorbable sutures, or both types combined, are employed [28,29,35,36].…”
mentioning
confidence: 99%